Rating History for Damora Therapeutics (DMRA) by H.C. Wainwright
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 6/11/2026 | Mitchell Kapoor | New Coverage | Buy (N/A) |
45.00 (N/A) |
20.15 (25.36) |
25.86% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 6/11/2026 | Mitchell Kapoor | New Coverage | Buy (N/A) |
45.00 (N/A) |
20.15 (25.36) |
25.86% | Details |